Anthony Eamon Storey
13Patents
5h-index
46Co-inventors
66Inventor score
Filing activity: Jul 11, 1996 → Jul 27, 2015
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6375926B1 | Labelled elastase inhibitors | Human Necessities | 14 | Expired |
| US6004531A | Metal chelating compounds having an SNNN donor set | Emerging Cross-Sectional Technologies | 9 | Expired |
| US5705143A | Biological targeting agents | Human Necessities | 6 | Expired |
| US8231858B2 | Diagnostic imaging agents with MMP inhibitory activity | Human Necessities | 6 | Active |
| US5932707A | Thioether-containing metal chelating compounds | Emerging Cross-Sectional Technologies | 5 | Expired |
| US8277777B2 | Compound having affinity for amyloid | Human Necessities | 2 | Active |
| US6653299B1 | Labelled factor XIIIa substrates | Human Necessities | 1 | Expired |
| US9126961B2 | Fluorination process | Emerging Cross-Sectional Technologies | 1 | Active |
| US7431914B2 | Contrast agent | Human Necessities | 1 | Expired |
| US7049289B1 | Labelled glutamine and lysine analogues | Human Necessities | 1 | Expired |
| US9468694B2 | Fluorination process | Emerging Cross-Sectional Technologies | 0 | Active |
| US6897209B2 | Labelled factor XIIIa substrates | Human Necessities | 0 | Expired |
| US8410312B2 | Fluorination process of anilide derivatives and benzothiazole fluorinate derivatives as in vivo imaging agents | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.